Literature DB >> 18424075

Long-term outcome of gamma-knife surgery in temporal lobe epilepsy.

Sylvain Rheims1, Catherine Fischer, Philippe Ryvlin, Jean Isnard, Marc Guenot, Manubu Tamura, Jean Regis, François Mauguiere.   

Abstract

PURPOSE: Indication of gamma-knife surgery (GKS) in temporal lobe epilepsy (TLE) remains a matter of debate. Either positive or negative results have been reported in studies with a maximum follow-up of 24 months. No long-term data have been published yet.
METHODS: We collected data from 15 TLE patients who underwent GKS and whose follow-up was longer than 24 months. Localisation and extension of the epileptogenic zone (EZ) were assessed by SEEG in eight patients. Ten patients were presenting with mesial TLE (mTLE) while in the other five SEEG showed that the EZ was extending beyond mesio-temporal structures. GKS procedure was targeted to the EZ at a dose of 21.1+/-2.6Gy at the margin.
RESULTS: The mean duration of the follow-up was 60+/-22.3 months. At last follow-up, seven patients (46.7%) were free of disabling seizure. The last seizure following GKS occurred on average after a delay of 19.75+/-20.62 months. No patient suffered recurrent seizures after a long period free of disabling seizures. No significant prognostic predictor could be individualized in this population. However, 6 of the 10 patients with mTLE (60%) were seizure free whereas only 1 of the 5 (20%) whose EZ was more extended exhibited the same seizure outcome.
CONCLUSION: When a positive outcome is achieved, the risk of seizure recurrence remains low at long term. In patients with typical mTLE, long-term GKS results may be closed to those observed after conventional surgery. Conversely, this procedure should not be proposed to patients in whom SEEG results suggest that the EZ is not restricted to mesial temporal structures.

Entities:  

Mesh:

Year:  2008        PMID: 18424075     DOI: 10.1016/j.eplepsyres.2008.03.003

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

Review 1.  Radiosurgery for epilepsy: clinical experience and potential antiepileptic mechanisms.

Authors:  Mark Quigg; John Rolston; Nicholas M Barbaro
Journal:  Epilepsia       Date:  2011-12-22       Impact factor: 5.864

2.  Neuropsychological outcomes after Gamma Knife radiosurgery for mesial temporal lobe epilepsy: a prospective multicenter study.

Authors:  Mark Quigg; Donna K Broshek; Nicholas M Barbaro; Mariann M Ward; Kenneth D Laxer; Guofen Yan; Kathleen Lamborn
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

3.  Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife ®) stereotactic system plans for acoustic schwannoma.

Authors:  Debnarayan Dutta; S Balaji Subramanian; V Murli; H Sudahar; P G Gopalakrishna Kurup; Mahadev Potharaju
Journal:  J Neurooncol       Date:  2011-09-04       Impact factor: 4.130

4.  Predictors of efficacy after stereotactic radiosurgery for medial temporal lobe epilepsy.

Authors:  E F Chang; M Quigg; M C Oh; W P Dillon; M M Ward; K D Laxer; D K Broshek; N M Barbaro
Journal:  Neurology       Date:  2010-01-12       Impact factor: 9.910

5.  Gamma knife radiosurgery for mesial temporal lobe epilepsy.

Authors:  John D Rolston; Mark Quigg; Nicholas M Barbaro
Journal:  Epilepsy Res Treat       Date:  2011-10-29

6.  Radiation-induced Cavernous Malformation as a Late Sequelae of Stereotactic Radiosurgery for Epilepsy.

Authors:  Ethan A Winkler; Caleb Rutledge; Mariann Ward; Tarik Tihan; Patricia K Sneed; Nicholas Barbaro; Paul Garcia; Michael McDermott; Edward F Chang
Journal:  Cureus       Date:  2018-03-11

Review 7.  An update on pediatric surgical epilepsy: Part II.

Authors:  Nisha Gadgil; Matthew Muir; Melissa A Lopresti; Sandi K Lam
Journal:  Surg Neurol Int       Date:  2019-12-27

8.  Resective, Ablative and Radiosurgical Interventions for Drug Resistant Mesial Temporal Lobe Epilepsy: A Systematic Review and Meta-Analysis of Outcomes.

Authors:  Kajol Marathe; Ali Alim-Marvasti; Karan Dahele; Fenglai Xiao; Sarah Buck; Aidan G O'Keeffe; John S Duncan; Vejay N Vakharia
Journal:  Front Neurol       Date:  2021-12-09       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.